Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 30 (6), 452-457

Pharmacotherapy of Eating Disorders


Pharmacotherapy of Eating Disorders

Haley Davis et al. Curr Opin Psychiatry.


Purpose of review: Medications are commonly prescribed in the treatment of eating disorders. In this review, we discuss relevant medications used for the treatment of bulimia nervosa, binge eating disorder (BED), and anorexia nervosa. We focus on recent research developments, where applicable, in addition to discussing important findings from older studies to provide a complete synopsis of the current evidence base for eating disorder treatment using pharmacologic agents.

Recent findings: Medications are generally useful for patients with bulimia nervosa and BED. For bulimia nervosa, antidepressant medications are the primary pharmacologic treatment and limited new research has been completed. For BED, lisdexamfetamine is reported to be generally well tolerated and effective, and is the first medication to be indicated by the US Food and Drug Administration for treatment of BED. For anorexia nervosa, there is limited evidence supporting benefits of medications. Second-generation antipsychotics, particularly olanzapine, appear to demonstrate some benefit for weight gain in anorexia nervosa, although are not advised as a stand-alone treatment. Transdermal administration of hormonal agents is also being explored for improving bone health in anorexia nervosa.

Summary: Although pharmacotherapy has established utility in bulimia nervosa and BED, further research on medications for the treatment of eating disorders, particularly anorexia nervosa, is necessary.

Similar articles

  • Towards the Pharmacotherapy of Eating Disorders
    KJ Pederson et al. Expert Opin Pharmacother 4 (10), 1659-78. PMID 14521477. - Review
    The purpose of this review is to discuss pharmacological options for the treatment of patients with eating disorders. Sequentially described are pharmacotherapy studies o …
  • Evidence-based Pharmacotherapy of Eating Disorders
    MF Flament et al. Int J Neuropsychopharmacol 15 (2), 189-207. PMID 21414249. - Review
    The objective was to review scientific evidence for efficacy and safety of pharmacotherapy in adults or children with an eating disorder (ED). We conducted a computer sea …
  • Biological Therapies for Eating Disorders
    JE Mitchell et al. Int J Eat Disord 46 (5), 470-7. PMID 23658094. - Review
    The bulimia nervosa (BN) literature underscores the utility of antidepressants, particularly SSRIs, in improving the symptoms of the disorder. The literature on binge eat …
  • Drug Therapy for Patients With Eating Disorders
    JE Mitchell et al. Curr Drug Targets CNS Neurol Disord 2 (1), 17-29. PMID 12769809. - Review
    The purpose of this article is to review the psychopharmacology treatment literature for patients with eating disorders including bulimia nervosa, anorexia nervosa and bi …
  • Emerging Drugs for Eating Disorder Treatment
    KJ Steffen et al. Expert Opin Emerg Drugs 11 (2), 315-36. PMID 16634704. - Review
    Anorexia nervosa (AN), bulimia nervosa (BN) and binge eating disorder (BED) comprise the currently recognised eating disorders. Although distinct diagnostic entities, the …
See all similar articles

Cited by 6 PubMed Central articles

See all "Cited by" articles

MeSH terms